𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Trial of Remitogen™ (Humanized 1D10) Monoclonal Antibody Targeting Class II in Patients with Relapsed Low-Grade or Follicular Lymphoma

✍ Scribed by Brown, Kevin S.; Levitt, Daniel J.; Shannon, Mary; Link, Brian K.


Book ID
119935708
Publisher
CIG Media Group, LP.
Year
2001
Tongue
English
Weight
94 KB
Volume
2
Category
Article
ISSN
1526-9655

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES